In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 33 for your search:
Drug:  recombinant interleukin-12
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000064977, NCI-96-C-0113F, NCI-T96-0029N, NCI-MB-386, T96-0029, NCT00019188

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 9018, UCCRC-9018, UCCRC-8381, NCI-G97-1162, NCT00002952

3.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-97002, ROCHE-BO15469, NCI-G97-1236

4.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-97-C-0118, NCI-T97-0009, T97-0009

5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-E1E96, E1E96, NCT00003017

6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-1A96, NCT00003149, E1A96

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GOG-170B

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02264, MDA-DM-97073, N01CM17003, CDR0000066067, NCI-T97-0050, T97-0050, NCT00003210

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066310 (10M-97-3), LAC-USC-10M973, NCI-G98-1432, NCI-T97-0099, T97-0099, NCT00003339

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: NCI-2012-02276, AMC-008, CDR0000066642, NCT00003575

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000068502, NCI-01-C-0067, NCI-4010, 4010, NCT00020449

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: 9845, UCCRC-9845, NCI-1192, NCT00015977

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02381, MDA-ID-00232, N01CM17003, CDR0000068619, NCI-2251, 2251, NCT00016289

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02816, CALGB-500001, CDR0000068990, U10CA031946, NCT00026143

15.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069220 (10M-01-1), LAC-USC-10M011, LAC-USC-IRB-013030, NCI-5506, 5506, NCT00031733

16.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-11447A, NCI-1330, NCT00064168, 1330

17.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: PCI-9432, DFCI-94044, NCI-V94-0495

18.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-95008, NCI-V95-0662

19.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-95-C-0143B, NCI-T95-0039N, T95-0039

20.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ID97-027, P30CA016672, MDA-ID-97027, NCI-T97-0034, CDR0000065681, T97-0034, NCT00003046

21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000066286, BIH-97-1083, NCI-T97-0053, T97-0053, NCT00003330

22.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 to 60
Sponsor: NCI
Protocol IDs: BIH-L97-0252, NCI-T98-0002, NCT00003412, T98-0002

23.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02272, PCI-98-031, PCI-MWH-97-039, NCI-T97-0031, CDR0000066467, T97-0031, NCT00003439

24.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 13 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01397, OSU-T98-0020, NCI-T98-0020, CDR0000066482, T98-0020, NCT00003451

25.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01398, 99H0185, U01CA076576, CDR0000067282, OSU-99H0185, OSU 9968, NCI-T99-0032, T99-0032, NCT00004074
1   
New Search